TCL Archive Science Policy: Increased Cancer Death Rate For Atomic Vets Not Significant, OIM Says October 29, 1999
TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005